RaySearch Laboratories AB (publ) (STO:RAY.B)
176.20
-3.40 (-1.89%)
Sep 2, 2026, 5:29 PM CET
RaySearch Laboratories AB Market Cap
RaySearch Laboratories AB has a market cap or net worth of 5.92 billion as of September 2, 2026. Its market cap has decreased by -32.24% in one year.
Market Cap
5.92B
Enterprise Value
6.07B
Revenue
1.27B
Ranking
n/a
PE Ratio
28.29
Stock Price
176.20
ChartMarket Cap Chart
Since October 30, 2003, RaySearch Laboratories AB's market cap has increased from 189.23M to 5.92B, an increase of 3,030.23%. That is a compound annual growth rate of 16.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 5.92B | -24.22% |
| Dec 30, 2025 | 7.82B | 5.56% |
| Dec 30, 2024 | 7.41B | 139.20% |
| Dec 29, 2023 | 3.10B | 32.79% |
| Dec 30, 2022 | 2.33B | 20.35% |
| Dec 30, 2021 | 1.94B | -31.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 158.85B |
| Getinge AB | 66.24B |
| Sectra AB | 56.45B |
| Medicover AB | 36.93B |
| MedCap AB | 8.40B |
| Xvivo Perfusion AB | 8.25B |
| Synsam AB | 8.23B |
| Dynavox Group AB | 8.03B |